Max W Chang Selected Research

Max W Chang Research Topics

7	Infections 01/2024 - 01/2018
5	COVID-19 01/2023 - 09/2020
2	Breakthrough Infections 01/2024 - 05/2023
2	Virus Diseases (Viral Diseases) 01/2021 - 09/2020
1	Lung Injury 01/2023
1	Critical Illness (Critically Ill) 01/2023
1	Drug Overdose 01/2022
1	Substance-Related Disorders (Drug Abuse) 01/2022
1	Hypertriglyceridemia 01/2019
1	Insulin Resistance 01/2018
1	Human Influenza (Influenza) 01/2018
1	Neoplasms (Cancer) 10/2017
1	Lung Neoplasms (Lung Cancer) 10/2017
1	Inflammation (Inflammations) 10/2015

3	Transcription Factors (Transcription Factor)IBA 01/2023 - 10/2017
2	VaccinesIBA 01/2024 - 05/2023
2	Neutralizing AntibodiesIBA 01/2024 - 05/2023
2	Messenger RNA (mRNA)IBA 01/2024 - 05/2023
2	InterferonsIBA 01/2021 - 09/2020
2	Viral RNAIBA 01/2021 - 09/2020
1	Opioid Analgesics (Opioids)IBA 01/2022
1	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 01/2022
1	NucleotidesIBA 08/2021
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2021
1	Antiviral Agents (Antivirals)IBA 12/2020
1	Nucleic AcidsIBA 09/2020
1	Carrier Proteins (Binding Protein)IBA 09/2020
1	Heparitin Sulfate (Heparan Sulfate)IBA 01/2020
1	Heparin Lyase (heparin lyase)IBA 01/2020
1	Triglycerides (Triacylglycerol)IBA 01/2019
1	HLA-DR Antigens (HLA-DR)IBA 01/2019
1	Lipoproteins (Lipoprotein)IBA 01/2019
1	ChromatinIBA 01/2018
1	Glucose (Dextrose)FDA LinkGeneric 01/2018
1	Phenobarbital (Luminal)FDA Link 01/2018
1	Cysteine (L-Cysteine)FDA Link 10/2017
1	AntioxidantsIBA 10/2017
1	DAX-1 Orphan Nuclear ReceptorIBA 10/2017
1	Insulin-Like PeptidesIBA 10/2015
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 10/2015

1	Therapeutics 10/2020